Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
LGND logo

LGND

NSD
Ligand Pharmaceuticals Incorporated
HealthcareBiotechnology
Watchlists:
Last updated: Friday 11th July 2025
124.98
+2.58 (2.11%)
Prev Close:122.4
Open:121.5
Bid:100.0
Ask:128.5
52 Week Range
90.29
129.90
Volume:120,090
Mkt Cap:2,221 M
Price Target
$143.73
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Moving Averages
Volatility Metrics
Financials

Financial Statements

LGND - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Basic Discontinuous Operations-0.1-1.670.02
Commission Expenses34 M47 M
Depreciation And Amortization2 M3 M4 M34 M2 M2 M16 M12 M11 M2 M
Diluted Discontinuous Operations-0.09-1.670.02
Earnings From Equity Interest-2 M-23 M-5 M
Earnings From Equity Interest Net Of Tax-2 M-23 M-5 M
Excise Taxes34 M17 M
Gain On Sale Of Business2 M1 M
Gain On Sale Of Security60 M46 M29 M-5 M-17 M1 M50 M12000.028 M
Gains Loss On Disposal Of Discontinued Operations731000.0
General And Administrative Expense79 M53 M70 M47 M64 M42 M38 M29 M28 M24 M
Gross Profit Margin (profit Margin After CGS)156 M121 M143 M179 M133 M109 M245 M136 M103 M66 M
Impairment Of Capital Assets17 M
Interest Expense Non Operating3 M656000.02 M20 M27 M36 M48 M13 M
Minority Interests767 M2 M
Misc Other Special Charges-55 M-2 M4 M-8 M-108000.0809 M-6 M3 M3 M2 M
Net Income (loss)-4 M52 M-33 M57 M-3 M629 M143 M13 M-3 M230 M
Net Income Common Stockholders-31 M52 M-33 M57 M-3 M629 M143 M13 M-3 M230 M
Net Income Continuous Operations-4 M54 M-5 M57 M-3 M629 M143 M13 M-3 M230 M
Net Income Discontinuous Operations-2 M-28 M-19 M731000.0
Net Income Extraordinary13 M-2 M
Net Non Operating Interest Income Expense5 M7 M247000.0-19 M-19 M-7 M-34 M-13 M
Net Operating Interest Income Expense-11 M-12 M-12 M
Operating Income-23 M12 M3 M104 M26 M807 M164 M68 M44 M28 M
Operating Income Before Depreciation (EBITDA)41 M101 M89 M143 M70 M896 M275 M94 M31 M48 M
Operating Expense190 M121 M140 M138 M178 M126 M-88 M-73 M-65 M-45 M
Other Gain Loss From Disposition Of Discontinued Operations-28 M-19 M
Other Gand A79 M53 M70 M47 M64 M42 M38 M29 M28 M24 M
Other Impairment Of Capital Assets31 M
Other Operating Expenses-58000.0-38 M-4 M-543000.0-1 M-1 M-70000.0-154000.0
Other Write Off300000.0
Rent And Landing Fees38 M29 M28 M24 M
Research Expense21 M25 M36 M32 M59 M56 M28 M27 M21 M11 M
Restructring And Mn A Income1 M1 M
Salaries And Wages34 M51 M29 M31 M25 M-21 M-25 M-19 M-12 M
Selling And Marketing Expense33 M34 M47 M
Total Income Available For Interest Expense (EBIT)6 M64 M38 M92 M19 M832 M222 M71 M8 M35 M
Total Revenues167 M131 M196 M242 M186 M120 M251 M141 M109 M72 M
Total Expenses201 M132 M193 M200 M208 M137 M-81 M-78 M-71 M-50 M
Total Revenue167 M131 M196 M242 M164 M120 M251 M141 M23 M28 M
Write Off23 M
Amord138 M137 M140 M34 M595 M210 M16 M12 M11 M2 M
Avgshs18 M17 M17 M27 M26 M30 M34 M34 M33 M32 M
Avgshsdt18 M18 M17 M28 M26 M32 M39 M38 M33 M34 M
Basiceps-0.223.02-1.982.15-0.1120.67
Basicepscont-0.223.11-0.312.15-0.1120.674.220.37-0.078.11
Cor11 M11 M53 M62 M30 M11 M6 M-5 M-6 M-6 M
Depamor4 M2 M2 M2 M-900000.0-400000.0-200000.0-200000.0
Dileps-0.222.94-1.982.06-0.1119.87
Dilepscont-0.223.03-0.312.06-0.1119.873.720.33-0.077.56
Intinc8 M8 M2 M886000.08 M28 M14 M
Netincdisc-4 M52 M-33 M57 M-3 M629 M143 M13 M-3 M230 M
Othincexp26 M-47 M33 M13 M17 M-810 M-44 M-3 M24 M-20 M
Othspecchg-38 M
Pretaxinc3 M64 M36 M72 M-11 M797 M173 M57 M8 M35 M
Resdev21 M25 M36 M32 M59 M56 M28 M27 M21 M11 M
Restruct1 M1 M
Sga112 M53 M104 M47 M64 M42 M38 M29 M28 M24 M
Shsout19 M18 M17 M27 M27 M26 M33 M34 M34 M33 M
Specincchg38 M-23 M-17 M-1 M-1 M
Taxprov7 M10 M41 M-4 M-5 M167 M30 M45 M10 M-192 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader